Yerevan
Tbilisi
Moscow
Paris
Los Angeles
Beijing
English
Հայերեն Русский
Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
Timeline
Unibank Launches Gift Cards New Education Platforms through Cooperation between AraratBank and Aren Mehrabyan FoundationTech Innovator and Winemaker Adam Kablanian Joins the Board of Trustees of the “Music for Future” FoundationUcom Reopens Sales and Service Center on Tigran Mets Avenue AraratBank Receives Visa Trusted Partnership Award 2025 Secret Santa at idplus: Anonymous Gift CardsWe condemn the unlawful actions by Armenia’s Gov. against the Armenian Apostolic Church. Jan Figel Free Style issues Armenia’s first corporate bonds in the fashion retail sector, placed by Cube InvestUnibank Completed the Placement of Its Third Issuance of Perpetual BondsScholarship for 100 Artsakh Students as Part of IDBank’s “Side by Side” Program The results of the second Junius financial literacy competition have been summarized From idea to implementation: Ameriabank Presents the Programs Implemented under My Ameria, My Armenia CSR Campaign Ucom and SunChild Launch the “Smart Birdwatching” Educational Program AraratBank Supports Digitization of "Karin" Scientific Center ArchiveWelcome to the ID booth: Big Christmas MarketWidest 5G Coverage, the Launch of the Uplay Platform, and the Integration of Cerillion: Ucom Summarizes 2025 Ucom and Armflix Present “13 Seconds” at KinoPark How to Choose a Career Path and What Skills are Considered Crucial: AraratBank on the GoTeach Platform Unibank Issues a New Tranche of Perpetual Bonds with 13.75% Coupon Unibank Became a Member of BAFT
All Timeline »
Life

Multiple sclerosis drug shows promising efficacy

The multiple sclerosis drug is showing promising efficacy in fighting relapses and reducing fatigue.

Back in March 2001, the US Food and Drug Administration approved a drug called ponosimod for use in adult patients with various types of multiple sclerosis. Only now there are research data that show that some drug reduces the number of relapses of the disease and can reduce fatigue - one of the characteristic symptoms of multiple sclerosis.

The respected scientific journal JAMA Neurology has found that ponesimod is more effective in fighting fatigue in multiple sclerosis than another commonly used drug called teriflunomide. It is superior to teriflunomide in reducing relapse rates and reducing the risk of new or existing lesions of myelin found on magnetic resonance imaging.

As reported by everydayhealth.com, ponesimod is used for various types of multiple sclerosis, including the most common relapsing remitting disease and active secondary progressive, which is the most severe. It is not accompanied by remissions and steadily leads to the disability of patients. It is people with this form of multiple sclerosis who show the appearance of new lesions of the myelin layer on MRI scans. Ponesimod must be taken once a day, treatment begins with a period of 14 days, then the doses are increased.